Braynelle’s Story: Living with Dravet Syndrome
December 3, 2023
Braynelle and Brandon have been managing their son Kai’s diagnosis of Dravet Syndrome since he was four months old. After starting medication distributed by Anovo, the frequency of Kai’s epileptic seizures has reduced dramatically, giving him the quality of life he deserves. In this video, Braynelle describes how the reliability of Anovo was able to return her peace of mind after years of uncertainty when it comes to the logistic challenges of managing her son’s rare disease.
“Anovo is always on my side.”
Related Posts
Cycle Pharmaceuticals and Anovo Deliver Relief to Those with Homozygous Cystinuria
Cycle Pharmaceuticals was founded in 2012 with one mission in mind: delivering best-in-class drug treatments and services to the underserved…
July 29, 2024
Advancing Rare Disease Care: Insights from the World Orphan Drug Congress and AAN Annual Meeting
The World Orphan Drug Congress (WODC) and the American Academy of Neurology (AAN) Annual Meeting are where healthcare leaders, advocates,…
June 11, 2024
Pyros and Anovo Partner to Elevate Care for Infantile Spasms
Pyros Pharmaceuticals works to elevate the standard of care for children with rare disease by pioneering treatment options like VIGPODER™…
April 1, 2024
